# Equon Pharmaceuticals, Inc. — Form D

Equon Pharmaceuticals, Inc. of HENDERSON, NV, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-26. The offering totals $3.5M. Industry: Biotechnology.

## Offering

- Filed: 2011-08-26
- Form: D
- Accession: 0001520581-11-000002
- Industry: Biotechnology
- Exemptions: 05
- Total offering: $3.5M
- Remaining: $3.5M
- Minimum investment: $100K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-165018

## Issuer

- Name: Equon Pharmaceuticals, Inc.
- CIK: 0001520581
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2007
- Address: 2764 N. GREEN VALLEY PARKWAY, HENDERSON, NV, 89014
- Phone: 858-437-7333

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Jeffrey Falk Taxson | Director | La Jolla, CA |
| Jeffrey Falk Taxson | Executive Officer | La Jolla, CA |

## More

- [CIK 1520581 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1520581&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001520581-11-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.